Medis Group D.o.o. (Slovenia)

Medis Group D.o.o. is a specialty pharmaceutical group headquartered in Ljubljana that provides market-access, commercialization and distribution services for innovative prescription medicines, biologics, rare-disease therapies, medical devices and diagnostics across Central and Eastern Europe. It combines regulatory affairs, pharmacovigilance, pricing and reimbursement, medical affairs, field forces, warehousing and GDP-compliant distribution under one platform. Medis focuses on specialty and hospital therapies such as oncology, neurology, immunology and rare diseases, complemented by OTC and consumer health products. It has a network of subsidiaries across Europe, enabling coordinated multi-market launches and unified commercial execution. Key assets include long-term partnerships with leading global pharma and biotech companies, deep regulatory expertise and strong distribution infrastructure. Medis positions itself as a full-service commercialization partner for high-value therapies in smaller and fragmented markets, aiming to accelerate patient access to innovative treatments.